Haplotype association mapping of acute lung injury in mice implicates activin A receptor, type 1

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 11, 2011, Pages 1499-1509

  Leikauf, George D ^a   Concel, Vincent J ^a   Liu, Pengyuan ^d   Bein, Kiflai ^a   Berndt, Annerose ^b   Ganguly, Koustav ^a   Jang, An Soo ^a,e   Brant, Kelly A ^a   Dietsch, Maggie ^f   Pope Varsalona, Hannah ^a   Dopico Jr , Richard A ^a   Di, Y P Peter ^a   Li, Qian ^f   Vuga, Louis J ^c   Medvedovic, Mario ^f   Kaminski, Naftali ^c   You, Ming ^d   Prows, Daniel R ^g,h  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Soonchunhyang University   (South Korea)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress syndrome; Carboxyl stress; Smoke inhalation; Transforming growth factor beta signaling; Ubiquitination

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR 1; BINDING PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; MYC PROTEIN; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; TETRATRICOPEPTIDE REPEAT PROTEIN; TRANSCRIPTION FACTOR ELK 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UBIQUITIN PROTEIN LIGASE COP1; VOLTAGE GATED CALCIUM CHANNEL;

3' UNTRANSLATED REGION; ACUTE LUNG INJURY; ACVR 1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CCDC 148 GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE MAP; INBRED STRAIN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; RPAP 2 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME;

ACROLEIN; ACTIVIN RECEPTORS, TYPE I; ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HAPLOTYPES; MICE; MICE, INBRED A; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ARRAY ANALYSIS;

EID: 79957969914     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201006-0912OC     Document Type: Article

References (84)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. (Pubitemid 30408719)
2. Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL. Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med 2009;3:283-297.
3. Bein K, Wesselkamper SC, Liu X, Dietsch M, Majumder N, Concel VJ, Medvedovic M, Sartor MA, Henning LN, Venditto C, et al. Surfactant-associated protein B is critical to survival in nickel-induced injury in mice. Am J Respir Cell Mol Biol 2009;41:226-236.
4. Traber DL, Hawkins HK, Enkhbaatar P, Cox RA, Schmalstieg FC, Zwischenberger JB, Traber LD. The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation. Pulm Pharmacol Ther 2007;20:163-166. (Pubitemid 44780153)
5. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD; NIH NHLBI ARDS Network. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37:1574-1579.
6. Tsushima K, King LS, Aggarwal NR, De Gorordo A, D'Alessio FR, Kubo K. Acute lung injury review. Intern Med 2009;48:621-630.
7. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA; NHLBI ARDS Clinical Trials Network. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010;137:288-296.
8. Leikauf GD, Leming LM, O'Donnell JR, Doupnik CA. Bronchial responsiveness and inflammation in guinea pigs exposed to acrolein. J Appl Physiol 1989;66:171-178. (Pubitemid 19056073)
9. Deshmukh HS, Shaver C, Case LM, Dietsch M, Wesselkamper SC, Hardie WD, Korfhagen TR, Corradi M, Nadel JA, Borchers MT, et al. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol 2008;38:446-454. (Pubitemid 351758691)
10. Deshmukh HS, McLachlan A, Atkinson JJ, Hardie WD, Korfhagen TR, Dietsch M, Liu Y, Di PY, Wesselkamper SC, Borchers MT, et al. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med 2009; 180:834-845.
11. Hales CA, Barkin PW, Jung W, Trautman E, Lamborghini D, Herrig N, Burke J. Synthetic smoke with acrolein but not HCl produces pulmonary edema. J Appl Physiol 1988;64:1121-1133. (Pubitemid 18088535)
12. Hales CA, Musto SW, Janssens S, Jung W, Quinn DA, Witten M. Smoke aldehyde component influences pulmonary edema. J Appl Physiol 1992;72:555-561.
13. Siempos II, Vardakas KZ, Kyriakopoulos CE, Ntaidou TK, Falagas ME. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock 2010;33:590-601.
14. Flores C, Pino-Yanes Mdel M, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008;12:R130.
15. Reddy AJ, Kleeberger SR. Genetic polymorphisms associated with acute lung injury. Pharmacogenomics 2009;10:1527-1539.
16. Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol 2009;296: L713-L725.
17. Sheu CC, Zhai R, Wang Z, Gong MN, Tejera P, Chen F, Su L, Thompson BT, Christiani DC. Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med 2009;35:1343-1351.
18. Mouse Genome Sequencing Consortium, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-562. (Pubitemid 35477048)
19. Pletcher MT, McClurg P, Batalov S, Su AI, Barnes SW, Lagler E, Korstanje R, Wang X, Nusskern D, Bogue MA, et al. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol 2004;2:e393.
20. Liu P, Wang Y, Vikis H, Maciag A, Wang D, Lu Y, Liu Y, You M. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet 2006;38:888-895. (Pubitemid 44141656)
21. Burgess-Herbert SL, Tsaih SW, Stylianou IM, Walsh K, Cox AJ, Paigen B. An experimental assessment of in silico haplotype association mapping in laboratory mice. BMC Genet 2009;10:81.
22. Liao G, Wang J, Guo J, Allard J, Cheng J, Ng A, Shafer S, Puech A, McPherson JD, Foernzler D, et al. In silico genetics: identification of a functional element regulating H2-Ealpha gene expression. Science 2004;306:690-695.
23. Liu P, Vikis H, Lu Y, Wang D, You M. Large-scale in silico mapping of complex quantitative traits in inbred mice. PLoS ONE 2007;2:e651.
24. Prows DR, Shertzer HG, Daly MJ, Sidman CL, Leikauf GD. Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat Genet 1997;17:471-474. (Pubitemid 27518400)
25. Wesselkamper SC, Prows DR, Biswas P, Willeke K, Bingham E, Leikauf GD. Genetic susceptibility to irritant-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2000;279:L575-L582.
26. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678.
27. Prows DR, Hafertepen AP, Winterberg AV, Gibbons WJ Jr, Wesselkamper SC, Singer JB, Hill AE, Nadeau JH, Leikauf GD. Reciprocal congenic lines of mice capture the aliq1 effect on acute lung injury survival time. Am J Respir Cell Mol Biol 2008;38:68-77.
28. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variant create synthetic genome-wide associations. PLoS Biol 2010;8: e1000294.
29. McDowell SA, Gammon K, Bachurski CJ, Wiest JS, Leikauf JE, Prows DR, Leikauf GD. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am J Respir Cell Mol Biol 2000;23:466-474.
30. Wesselkamper SC, McDowell SA, Medvedovic M, Dalton TP, Deshmukh HS, Sartor MA, Case LM, Henning LN, Borchers MT, Tomlinson CR, et al. The role of metallothionein in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol 2006;34:73-82. (Pubitemid 43042859)
31. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Curr Drug Targets 2010;11:1485-1494.
32. Schug J. Chapter 2.6. Using TESS to Predict Transcription Factor Binding Sites in DNA Sequence. In: Current protocols in bioinformatics. Baxevanis AD, editors. New York, NY: J. Wiley and Sons; 2003.
33. Sigrist CJA, Cerutti L, Hulo N, Gattiker A, Falquet L, Pagni M, Bairoch A, Bucher P. PROSITE: a documented database using patterns and profiles as motif descriptors. Brief Bioinform 2002;3:265-274.
34. Ganguly K, Stoeger T, Wesselkamper SC, Reinhart C, Sartor MA, Medvedovic M, Tomlinson CR, Bolle I, Mason JM, Leikauf GD, et al. Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure. Physiol Genomics 2007;31: 410-421. (Pubitemid 350127781)
35. Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009;360:1696-1698.
36. Kraft P, Hunter DJ. Genetic risk prediction-are we there yet? N Engl J Med 2009;360:1701-1703.
37. Dermitzakis ET, Clark AG. Genetics. Life after GWA studies. Science 2009;326:239-240.
38. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753.
39. Hirschhorn JN. Genomewide association studies-illuminating biologic pathways. N Engl J Med 2009;360:1699-1701.
40. Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev 1992;6:691-704.
41. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 1992;6:2235-2247. (Pubitemid 23037390)
42. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE, et al. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev Biol 2005;283:226-239.
43. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
44. Mishina Y, Crombie R, Bradley A, Behringer RR. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol 1999;213:314-326. (Pubitemid 29444342)
45. Gu Z, Reynolds EM, Song J, Lei H, Feijen A, Yu L, He W, MacLaughlin DT, van den Eijnden-van Raaij J, Donahoe PK, et al. The type I serine/ threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 1999;126:2551-2561. (Pubitemid 29299023)
46. Komatsu Y, Scott G, Nagy A, Kaartinen V, Mishina Y. BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis. Dev Dyn 2007;236:512-517. (Pubitemid 46233294)
47. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-527.
48. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 2009;30:379-390.
49. Song GA, Kim HJ, Woo KM, Baek JH, Kim GS, Choi JY, Ryoo HM. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J Biol Chem 2010;285:22542-22553.
50. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein M L, Hong DW, McManus PM, Katagiri T, Sachidanandan C, et al. BMP type I receptor inhibition reduces heterotropic ossification. Nat Med 2008; 14:1363-1369.
51. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 1994;14:5961-5974. (Pubitemid 24264425)
52. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584. (Pubitemid 37280136)
53. Renlund N, O'Neill FH, Zhang L, Sidis Y, Teixeira J. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor. J Endocrinol 2007;195:95-103. (Pubitemid 350056003)
54. Kevenaar ME, Themmen AP, van Kerkwijk AJ, Valkenburg O, Uitterlinden AG, de Jong FH, Laven JS, Visser JA. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod 2009;24:241-249.
55. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996;10:1580-1594. (Pubitemid 26268864)
56. Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O, De Langhe S, Kemp PJ, Riccardi D, Torday J, et al. Lung organogenesis. Curr Top Dev Biol 2010;90:73-158.
57. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 1995;10:1651-1659.
58. Ebendal T, Bengtsson H, Söderström S. Bone morphogenetic proteins and their receptors: potential functions in the brain. J Neurosci Res 1998;51:139-146. (Pubitemid 28073021)
59. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 1997;389:622-666.
60. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 1997;94:9314-9319. (Pubitemid 27357826)
61. Zhao J, Shi W, Chen H, Warburton D. Smad7 and Smad6 differentially modulate transforming growth factor beta-induced inhibition of embryonic lung morphogenesis. J Biol Chem 2000;275:23992-23997. (Pubitemid 30624689)
62. Afrakhte M, Morén A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun 1998;249:505-511.
63. Adiseshaiah P, Kalvakolanu DV, Reddy SP. A JNK-independent signaling pathway regulates TNF alpha-stimulated, c-Jun-driven FRA-1 protooncogene transcription in pulmonary epithelial cells. J Immunol 2006;177:7193-7202. (Pubitemid 44715088)
64. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107: 1537-1544. (Pubitemid 32574640)
65. Dhainaut JF, Charpentier J, Chiche JD. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003;31:S258-S264. (Pubitemid 36458177)
66. Wesselkamper SC, Case LM, Henning LN, Borchers MT, Tichelaar JW, Mason JM, Dragin N, Medvedovic M, Sartor MA, Tomlinson CR, et al. Gene expression changes during the development of acute lung injury: role of transforming growth factor beta. Am J Respir Crit Care Med 2005;172:1399-1411. (Pubitemid 43069813)
67. Hamacher J, Lucas R, Lijnen HR, Buschke S, Dunant Y, Wendel A, Grau GE, Suter PM, Ricou B. Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;1660:651-656. (Pubitemid 34971845)
68. Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol 2003;28:499-503. (Pubitemid 36399372)
69. Budinger GR, Chandel NS, Donnelly HK, Eisenbart J, Oberoi M, Jain M. Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005;31:121-128. (Pubitemid 40174291)
70. Synenki L, Chandel NS, Budinger GR, Donnelly HK, Topin J, Eisenbart J, Jovanovic B, Jain M. Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation. Crit Care Med 2007;35:842-848. (Pubitemid 46407800)
71. Hurst V IV, Goldberg PL, Minnear FL, Heimark RL, Vincent PA. Rearrangement of adherens junctions by transforming growth factor-beta1: role of contraction. Am J Physiol 1999;276:L582-L595.
72. Ganter MT, Roux J, Miyazawa B, Howard M, Frank JA, Su G, Sheppard D, Violette SM, Weinreb PH, Horan GS, et al. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circ Res 2008;102:804-812. (Pubitemid 351521585)
73. Frank J, Roux J, Kawakatsu H, Su G, Dagenais A, Berthiaume Y, Howard M, Canessa CM, Fang X, Sheppard D, et al. Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism. J Biol Chem 2003; 278:43939-43950. (Pubitemid 37377133)
74. Roux J, Carles M, Koh H, Goolaerts A, Ganter MT, Chesebro BB, Howard M, Houseman BT, Finkbeiner W, Shokat KM, et al. Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2010;285:4278-4290.
75. Song Y, Masison DC. Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1 (Hop1). J Biol Chem 2005;280:34178-34185. (Pubitemid 41443142)
76. Vos MJ, Hageman J, Carra S, Kampinga HH. Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 2008;47:7001-7011. (Pubitemid 351956349)
77. Inoue Y, Imamura T. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci 2008;99:2107-2112.
78. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005;307:1621-1625. (Pubitemid 40354744)
79. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004;429:86-92. (Pubitemid 38620556)
80. Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem 2003;278:19682-19690. (Pubitemid 36799153)
81. Kato S, Ding J, Pisck E, Jhala US, Du K. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem 2008;283:35464-35473.
82. Yi C, Li S, Chen X, Wiemer EA, Wang J, Wei N, Deng XW. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res 2005;65:5835-5840. (Pubitemid 40911188)
83. Bein K, Leight H, Leikauf GD. JUN-CCAAT/enhancer binding protein (C/EBP) complexes inhibit surfactant associated protein B promoter activity. Am J Respir Cell Mol Biol. 2010; Dec 10 [Epub ahead of print]
84. Jang AS, Concel VJ, Bein K, Brant KA, Liu S, Pope-Varsalona H, Dopico Jr RA, Di YP, Knoell DL, Barchowsky A, Leikauf GD. Endothelial dysfunction and Claudin 5 regulation during acrolein-induced lung injury. Am J Respir Cell Mol Biol 2011;44: 483-490.